Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
1997-12-9
|
pubmed:abstractText |
In a model of volume-controlled hemorrhagic shock in rats, invariably leading to death within 30 min of bleeding termination, the intravenous (i.v.) bolus injection of ACTH-(1-24) at the dose of 0.16 mg/kg restored cardiovascular and respiratory functions and greatly prolonged survival. I.v. or intracerebroventricular (i.c.v.) treatment with NG-nitro-L-arginine methylester (L-NAME), a non-isoform-selective inhibitor of nitric oxide synthases (NOSs), at the doses of 2.5-10 mg/kg i.v. or 0.015-0.135 mg/kg i.c.v., as well as i.v. treatment with S-methylisothiourea (SMT), a selective inhibitor of the inducible isoform of NOS, at the doses of 0.001-3 mg/kg, dose-dependently improved cardiovascular and respiratory functions and potentiated the effect of a subthreshold dose (0.02 mg/kg) of ACTH-(1-24). On the other hand, either intraperitoneal or i.c.v. pretreatment with L-arginine, the substrate of NOSs, prevented the effect of ACTH-(1-24). These data suggest that inhibition of NO overproduction is involved in the mechanism of action of ACTH-(1-24) in shock reversal.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Cosyntropin,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Isothiuronium,
http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/S-methylisothiopseudouronium
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1889-97
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9364193-Animals,
pubmed-meshheading:9364193-Arginine,
pubmed-meshheading:9364193-Cosyntropin,
pubmed-meshheading:9364193-Disease Models, Animal,
pubmed-meshheading:9364193-Dose-Response Relationship, Drug,
pubmed-meshheading:9364193-Drug Synergism,
pubmed-meshheading:9364193-Enzyme Inhibitors,
pubmed-meshheading:9364193-Female,
pubmed-meshheading:9364193-Isothiuronium,
pubmed-meshheading:9364193-Male,
pubmed-meshheading:9364193-NG-Nitroarginine Methyl Ester,
pubmed-meshheading:9364193-Nitric Oxide Synthase,
pubmed-meshheading:9364193-Rats,
pubmed-meshheading:9364193-Rats, Wistar,
pubmed-meshheading:9364193-Shock, Hemorrhagic
|
pubmed:year |
1997
|
pubmed:articleTitle |
Inhibition of nitric oxide synthases enhances the effect of ACTH in hemorrhagic shock.
|
pubmed:affiliation |
Department of Biomedical Sciences, University of Modena, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|